GSK-404286/001

Study Sponsor: GSK

Study Title

Feasibility Double-blindDTPa-HBV-IPV/HIB-MenC control : DTPa-HBV-IPV + HiberixLot D21798A2;D21799B2;DCH002A46;DCH003A46;Hib400A47/MInfants 2-3 months

Medicine or Vaccine (generic name)

Meningococcal Serogroups A, C, W-135 and Y Vaccine

Sponsor Identification Number

404286/001

Trial Registry Identification Number(#'s)

N/A

Medical Condition

Infections, Meningococcal

Phase

Phase 2

Link to GSK Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A follow-on study 404286/006 was conducted. There is no GSK Study Register entry for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

February 2016